nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—Melatonin—MPO—atherosclerosis	0.0039	0.571	CrCbGaD
Rizatriptan—Melatonin—ESR1—atherosclerosis	0.00292	0.429	CrCbGaD
Rizatriptan—Arthralgia—Rosuvastatin—atherosclerosis	0.00225	0.00328	CcSEcCtD
Rizatriptan—Myalgia—Rosuvastatin—atherosclerosis	0.00225	0.00328	CcSEcCtD
Rizatriptan—Flushing—Simvastatin—atherosclerosis	0.00223	0.00326	CcSEcCtD
Rizatriptan—Mental disorder—Ezetimibe—atherosclerosis	0.00221	0.00322	CcSEcCtD
Rizatriptan—Flatulence—Lovastatin—atherosclerosis	0.00221	0.00322	CcSEcCtD
Rizatriptan—Hypoaesthesia—Niacin—atherosclerosis	0.0022	0.00321	CcSEcCtD
Rizatriptan—Erythema—Ezetimibe—atherosclerosis	0.0022	0.0032	CcSEcCtD
Rizatriptan—Dysgeusia—Lovastatin—atherosclerosis	0.00219	0.0032	CcSEcCtD
Rizatriptan—Confusional state—Rosuvastatin—atherosclerosis	0.00217	0.00317	CcSEcCtD
Rizatriptan—Hypoaesthesia—Pravastatin—atherosclerosis	0.00216	0.00316	CcSEcCtD
Rizatriptan—Flatulence—Ezetimibe—atherosclerosis	0.00216	0.00316	CcSEcCtD
Rizatriptan—Pharyngitis—Pravastatin—atherosclerosis	0.00216	0.00315	CcSEcCtD
Rizatriptan—Chills—Simvastatin—atherosclerosis	0.00216	0.00315	CcSEcCtD
Rizatriptan—Muscle spasms—Lovastatin—atherosclerosis	0.00215	0.00314	CcSEcCtD
Rizatriptan—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00211	0.00308	CcSEcCtD
Rizatriptan—Muscle spasms—Ezetimibe—atherosclerosis	0.00211	0.00308	CcSEcCtD
Rizatriptan—Vision blurred—Lovastatin—atherosclerosis	0.00211	0.00308	CcSEcCtD
Rizatriptan—Mental disorder—Simvastatin—atherosclerosis	0.00211	0.00307	CcSEcCtD
Rizatriptan—Tremor—Lovastatin—atherosclerosis	0.0021	0.00306	CcSEcCtD
Rizatriptan—Erythema—Simvastatin—atherosclerosis	0.00209	0.00306	CcSEcCtD
Rizatriptan—Flatulence—Simvastatin—atherosclerosis	0.00206	0.00301	CcSEcCtD
Rizatriptan—Tinnitus—Niacin—atherosclerosis	0.00206	0.003	CcSEcCtD
Rizatriptan—Dysgeusia—Simvastatin—atherosclerosis	0.00205	0.00299	CcSEcCtD
Rizatriptan—Flushing—Niacin—atherosclerosis	0.00205	0.00299	CcSEcCtD
Rizatriptan—Angioedema—Lovastatin—atherosclerosis	0.00205	0.00298	CcSEcCtD
Rizatriptan—Tinnitus—Pravastatin—atherosclerosis	0.00203	0.00296	CcSEcCtD
Rizatriptan—Flushing—Pravastatin—atherosclerosis	0.00202	0.00294	CcSEcCtD
Rizatriptan—Muscle spasms—Simvastatin—atherosclerosis	0.00201	0.00294	CcSEcCtD
Rizatriptan—Vertigo—Lovastatin—atherosclerosis	0.00201	0.00293	CcSEcCtD
Rizatriptan—Angioedema—Ezetimibe—atherosclerosis	0.00201	0.00293	CcSEcCtD
Rizatriptan—Angiopathy—Niacin—atherosclerosis	0.002	0.00292	CcSEcCtD
Rizatriptan—Chills—Niacin—atherosclerosis	0.00198	0.00289	CcSEcCtD
Rizatriptan—Vision blurred—Simvastatin—atherosclerosis	0.00197	0.00288	CcSEcCtD
Rizatriptan—Arrhythmia—Niacin—atherosclerosis	0.00197	0.00288	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00196	0.00287	CcSEcCtD
Rizatriptan—Tremor—Simvastatin—atherosclerosis	0.00196	0.00286	CcSEcCtD
Rizatriptan—Chills—Pravastatin—atherosclerosis	0.00195	0.00285	CcSEcCtD
Rizatriptan—Insomnia—Rosuvastatin—atherosclerosis	0.00195	0.00284	CcSEcCtD
Rizatriptan—Arrhythmia—Pravastatin—atherosclerosis	0.00194	0.00283	CcSEcCtD
Rizatriptan—Palpitations—Ezetimibe—atherosclerosis	0.00194	0.00283	CcSEcCtD
Rizatriptan—Paraesthesia—Rosuvastatin—atherosclerosis	0.00194	0.00282	CcSEcCtD
Rizatriptan—Erythema—Niacin—atherosclerosis	0.00192	0.00281	CcSEcCtD
Rizatriptan—Cough—Ezetimibe—atherosclerosis	0.00192	0.0028	CcSEcCtD
Rizatriptan—Angioedema—Simvastatin—atherosclerosis	0.00191	0.00279	CcSEcCtD
Rizatriptan—Chest pain—Lovastatin—atherosclerosis	0.00191	0.00278	CcSEcCtD
Rizatriptan—Myalgia—Lovastatin—atherosclerosis	0.00191	0.00278	CcSEcCtD
Rizatriptan—Arthralgia—Lovastatin—atherosclerosis	0.00191	0.00278	CcSEcCtD
Rizatriptan—Anxiety—Lovastatin—atherosclerosis	0.0019	0.00277	CcSEcCtD
Rizatriptan—Dyspepsia—Rosuvastatin—atherosclerosis	0.0019	0.00277	CcSEcCtD
Rizatriptan—Hypertension—Ezetimibe—atherosclerosis	0.0019	0.00277	CcSEcCtD
Rizatriptan—Flatulence—Niacin—atherosclerosis	0.00189	0.00276	CcSEcCtD
Rizatriptan—Tension—Niacin—atherosclerosis	0.00189	0.00275	CcSEcCtD
Rizatriptan—Discomfort—Lovastatin—atherosclerosis	0.00188	0.00275	CcSEcCtD
Rizatriptan—Vertigo—Simvastatin—atherosclerosis	0.00188	0.00274	CcSEcCtD
Rizatriptan—Arthralgia—Ezetimibe—atherosclerosis	0.00187	0.00273	CcSEcCtD
Rizatriptan—Chest pain—Ezetimibe—atherosclerosis	0.00187	0.00273	CcSEcCtD
Rizatriptan—Myalgia—Ezetimibe—atherosclerosis	0.00187	0.00273	CcSEcCtD
Rizatriptan—Nervousness—Niacin—atherosclerosis	0.00187	0.00272	CcSEcCtD
Rizatriptan—Flatulence—Pravastatin—atherosclerosis	0.00187	0.00272	CcSEcCtD
Rizatriptan—Dry mouth—Lovastatin—atherosclerosis	0.00186	0.00272	CcSEcCtD
Rizatriptan—Tension—Pravastatin—atherosclerosis	0.00186	0.00271	CcSEcCtD
Rizatriptan—Dysgeusia—Pravastatin—atherosclerosis	0.00185	0.0027	CcSEcCtD
Rizatriptan—Muscle spasms—Niacin—atherosclerosis	0.00185	0.0027	CcSEcCtD
Rizatriptan—Discomfort—Ezetimibe—atherosclerosis	0.00185	0.00269	CcSEcCtD
Rizatriptan—Pain—Rosuvastatin—atherosclerosis	0.00184	0.00269	CcSEcCtD
Rizatriptan—Constipation—Rosuvastatin—atherosclerosis	0.00184	0.00269	CcSEcCtD
Rizatriptan—Confusional state—Lovastatin—atherosclerosis	0.00184	0.00269	CcSEcCtD
Rizatriptan—Nervousness—Pravastatin—atherosclerosis	0.00184	0.00268	CcSEcCtD
Rizatriptan—Dry mouth—Ezetimibe—atherosclerosis	0.00183	0.00267	CcSEcCtD
Rizatriptan—Anaphylactic shock—Lovastatin—atherosclerosis	0.00183	0.00267	CcSEcCtD
Rizatriptan—Muscle spasms—Pravastatin—atherosclerosis	0.00182	0.00266	CcSEcCtD
Rizatriptan—Vision blurred—Niacin—atherosclerosis	0.00181	0.00264	CcSEcCtD
Rizatriptan—Confusional state—Ezetimibe—atherosclerosis	0.00181	0.00264	CcSEcCtD
Rizatriptan—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00179	0.00261	CcSEcCtD
Rizatriptan—Vision blurred—Pravastatin—atherosclerosis	0.00178	0.0026	CcSEcCtD
Rizatriptan—Arthralgia—Simvastatin—atherosclerosis	0.00178	0.0026	CcSEcCtD
Rizatriptan—Myalgia—Simvastatin—atherosclerosis	0.00178	0.0026	CcSEcCtD
Rizatriptan—Chest pain—Simvastatin—atherosclerosis	0.00178	0.0026	CcSEcCtD
Rizatriptan—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00178	0.00259	CcSEcCtD
Rizatriptan—Anxiety—Simvastatin—atherosclerosis	0.00178	0.00259	CcSEcCtD
Rizatriptan—Tremor—Pravastatin—atherosclerosis	0.00177	0.00259	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00176	0.00257	CcSEcCtD
Rizatriptan—Discomfort—Simvastatin—atherosclerosis	0.00176	0.00257	CcSEcCtD
Rizatriptan—Nervous system disorder—Ezetimibe—atherosclerosis	0.00176	0.00256	CcSEcCtD
Rizatriptan—Angioedema—Niacin—atherosclerosis	0.00176	0.00256	CcSEcCtD
Rizatriptan—Anorexia—Lovastatin—atherosclerosis	0.00174	0.00254	CcSEcCtD
Rizatriptan—Angioedema—Pravastatin—atherosclerosis	0.00173	0.00252	CcSEcCtD
Rizatriptan—Vertigo—Niacin—atherosclerosis	0.00173	0.00252	CcSEcCtD
Rizatriptan—Syncope—Niacin—atherosclerosis	0.00172	0.00252	CcSEcCtD
Rizatriptan—Confusional state—Simvastatin—atherosclerosis	0.00172	0.00251	CcSEcCtD
Rizatriptan—Urticaria—Rosuvastatin—atherosclerosis	0.00171	0.0025	CcSEcCtD
Rizatriptan—Anaphylactic shock—Simvastatin—atherosclerosis	0.00171	0.00249	CcSEcCtD
Rizatriptan—Oedema—Simvastatin—atherosclerosis	0.00171	0.00249	CcSEcCtD
Rizatriptan—Abdominal pain—Rosuvastatin—atherosclerosis	0.0017	0.00249	CcSEcCtD
Rizatriptan—Vertigo—Pravastatin—atherosclerosis	0.0017	0.00248	CcSEcCtD
Rizatriptan—Palpitations—Niacin—atherosclerosis	0.0017	0.00248	CcSEcCtD
Rizatriptan—Loss of consciousness—Niacin—atherosclerosis	0.00169	0.00247	CcSEcCtD
Rizatriptan—Cough—Niacin—atherosclerosis	0.00168	0.00245	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00166	0.00243	CcSEcCtD
Rizatriptan—Insomnia—Lovastatin—atherosclerosis	0.00165	0.00241	CcSEcCtD
Rizatriptan—Cough—Pravastatin—atherosclerosis	0.00165	0.00241	CcSEcCtD
Rizatriptan—Paraesthesia—Lovastatin—atherosclerosis	0.00164	0.00239	CcSEcCtD
Rizatriptan—Arthralgia—Niacin—atherosclerosis	0.00164	0.00239	CcSEcCtD
Rizatriptan—Myalgia—Niacin—atherosclerosis	0.00164	0.00239	CcSEcCtD
Rizatriptan—Hypertension—Pravastatin—atherosclerosis	0.00163	0.00238	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00163	0.00238	CcSEcCtD
Rizatriptan—Anorexia—Simvastatin—atherosclerosis	0.00163	0.00238	CcSEcCtD
Rizatriptan—Dyspnoea—Lovastatin—atherosclerosis	0.00163	0.00238	CcSEcCtD
Rizatriptan—Insomnia—Ezetimibe—atherosclerosis	0.00162	0.00236	CcSEcCtD
Rizatriptan—Arthralgia—Pravastatin—atherosclerosis	0.00161	0.00235	CcSEcCtD
Rizatriptan—Chest pain—Pravastatin—atherosclerosis	0.00161	0.00235	CcSEcCtD
Rizatriptan—Myalgia—Pravastatin—atherosclerosis	0.00161	0.00235	CcSEcCtD
Rizatriptan—Paraesthesia—Ezetimibe—atherosclerosis	0.00161	0.00235	CcSEcCtD
Rizatriptan—Dyspepsia—Lovastatin—atherosclerosis	0.00161	0.00235	CcSEcCtD
Rizatriptan—Anxiety—Pravastatin—atherosclerosis	0.00161	0.00234	CcSEcCtD
Rizatriptan—Dry mouth—Niacin—atherosclerosis	0.0016	0.00234	CcSEcCtD
Rizatriptan—Dyspnoea—Ezetimibe—atherosclerosis	0.0016	0.00233	CcSEcCtD
Rizatriptan—Discomfort—Pravastatin—atherosclerosis	0.00159	0.00232	CcSEcCtD
Rizatriptan—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00159	0.00232	CcSEcCtD
Rizatriptan—Decreased appetite—Lovastatin—atherosclerosis	0.00159	0.00232	CcSEcCtD
Rizatriptan—Dyspepsia—Ezetimibe—atherosclerosis	0.00158	0.0023	CcSEcCtD
Rizatriptan—Fatigue—Lovastatin—atherosclerosis	0.00158	0.0023	CcSEcCtD
Rizatriptan—Oedema—Niacin—atherosclerosis	0.00157	0.00229	CcSEcCtD
Rizatriptan—Anaphylactic shock—Niacin—atherosclerosis	0.00157	0.00229	CcSEcCtD
Rizatriptan—Pain—Lovastatin—atherosclerosis	0.00156	0.00228	CcSEcCtD
Rizatriptan—Constipation—Lovastatin—atherosclerosis	0.00156	0.00228	CcSEcCtD
Rizatriptan—Confusional state—Pravastatin—atherosclerosis	0.00156	0.00227	CcSEcCtD
Rizatriptan—Decreased appetite—Ezetimibe—atherosclerosis	0.00156	0.00227	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00156	0.00227	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00155	0.00226	CcSEcCtD
Rizatriptan—Asthenia—Rosuvastatin—atherosclerosis	0.00155	0.00226	CcSEcCtD
Rizatriptan—Insomnia—Simvastatin—atherosclerosis	0.00155	0.00226	CcSEcCtD
Rizatriptan—Anaphylactic shock—Pravastatin—atherosclerosis	0.00154	0.00225	CcSEcCtD
Rizatriptan—Oedema—Pravastatin—atherosclerosis	0.00154	0.00225	CcSEcCtD
Rizatriptan—Fatigue—Ezetimibe—atherosclerosis	0.00154	0.00225	CcSEcCtD
Rizatriptan—Shock—Niacin—atherosclerosis	0.00154	0.00225	CcSEcCtD
Rizatriptan—Paraesthesia—Simvastatin—atherosclerosis	0.00153	0.00224	CcSEcCtD
Rizatriptan—Constipation—Ezetimibe—atherosclerosis	0.00153	0.00224	CcSEcCtD
Rizatriptan—Pain—Ezetimibe—atherosclerosis	0.00153	0.00224	CcSEcCtD
Rizatriptan—Tachycardia—Niacin—atherosclerosis	0.00153	0.00223	CcSEcCtD
Rizatriptan—Pruritus—Rosuvastatin—atherosclerosis	0.00153	0.00223	CcSEcCtD
Rizatriptan—Dyspnoea—Simvastatin—atherosclerosis	0.00152	0.00222	CcSEcCtD
Rizatriptan—Hyperhidrosis—Niacin—atherosclerosis	0.00152	0.00221	CcSEcCtD
Rizatriptan—Feeling abnormal—Lovastatin—atherosclerosis	0.00151	0.0022	CcSEcCtD
Rizatriptan—Dyspepsia—Simvastatin—atherosclerosis	0.0015	0.00219	CcSEcCtD
Rizatriptan—Anorexia—Niacin—atherosclerosis	0.0015	0.00218	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00149	0.00218	CcSEcCtD
Rizatriptan—Hyperhidrosis—Pravastatin—atherosclerosis	0.00149	0.00218	CcSEcCtD
Rizatriptan—Decreased appetite—Simvastatin—atherosclerosis	0.00149	0.00217	CcSEcCtD
Rizatriptan—Feeling abnormal—Ezetimibe—atherosclerosis	0.00148	0.00215	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00148	0.00215	CcSEcCtD
Rizatriptan—Diarrhoea—Rosuvastatin—atherosclerosis	0.00148	0.00215	CcSEcCtD
Rizatriptan—Fatigue—Simvastatin—atherosclerosis	0.00147	0.00215	CcSEcCtD
Rizatriptan—Anorexia—Pravastatin—atherosclerosis	0.00147	0.00215	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00147	0.00214	CcSEcCtD
Rizatriptan—Constipation—Simvastatin—atherosclerosis	0.00146	0.00213	CcSEcCtD
Rizatriptan—Pain—Simvastatin—atherosclerosis	0.00146	0.00213	CcSEcCtD
Rizatriptan—Urticaria—Lovastatin—atherosclerosis	0.00145	0.00212	CcSEcCtD
Rizatriptan—Abdominal pain—Lovastatin—atherosclerosis	0.00144	0.00211	CcSEcCtD
Rizatriptan—Body temperature increased—Lovastatin—atherosclerosis	0.00144	0.00211	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00143	0.00209	CcSEcCtD
Rizatriptan—Dizziness—Rosuvastatin—atherosclerosis	0.00143	0.00208	CcSEcCtD
Rizatriptan—Urticaria—Ezetimibe—atherosclerosis	0.00142	0.00208	CcSEcCtD
Rizatriptan—Insomnia—Niacin—atherosclerosis	0.00142	0.00207	CcSEcCtD
Rizatriptan—Abdominal pain—Ezetimibe—atherosclerosis	0.00142	0.00207	CcSEcCtD
Rizatriptan—Body temperature increased—Ezetimibe—atherosclerosis	0.00142	0.00207	CcSEcCtD
Rizatriptan—Paraesthesia—Niacin—atherosclerosis	0.00141	0.00206	CcSEcCtD
Rizatriptan—Feeling abnormal—Simvastatin—atherosclerosis	0.00141	0.00205	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00141	0.00205	CcSEcCtD
Rizatriptan—Dyspnoea—Niacin—atherosclerosis	0.0014	0.00204	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0014	0.00204	CcSEcCtD
Rizatriptan—Insomnia—Pravastatin—atherosclerosis	0.0014	0.00204	CcSEcCtD
Rizatriptan—Somnolence—Niacin—atherosclerosis	0.00139	0.00204	CcSEcCtD
Rizatriptan—Paraesthesia—Pravastatin—atherosclerosis	0.00139	0.00202	CcSEcCtD
Rizatriptan—Dyspepsia—Niacin—atherosclerosis	0.00138	0.00202	CcSEcCtD
Rizatriptan—Dyspnoea—Pravastatin—atherosclerosis	0.00138	0.00201	CcSEcCtD
Rizatriptan—Decreased appetite—Niacin—atherosclerosis	0.00136	0.00199	CcSEcCtD
Rizatriptan—Dyspepsia—Pravastatin—atherosclerosis	0.00136	0.00198	CcSEcCtD
Rizatriptan—Rash—Rosuvastatin—atherosclerosis	0.00136	0.00198	CcSEcCtD
Rizatriptan—Dermatitis—Rosuvastatin—atherosclerosis	0.00136	0.00198	CcSEcCtD
Rizatriptan—Urticaria—Simvastatin—atherosclerosis	0.00136	0.00198	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Niacin—atherosclerosis	0.00135	0.00198	CcSEcCtD
Rizatriptan—Body temperature increased—Simvastatin—atherosclerosis	0.00135	0.00197	CcSEcCtD
Rizatriptan—Abdominal pain—Simvastatin—atherosclerosis	0.00135	0.00197	CcSEcCtD
Rizatriptan—Headache—Rosuvastatin—atherosclerosis	0.00135	0.00197	CcSEcCtD
Rizatriptan—Hypersensitivity—Lovastatin—atherosclerosis	0.00135	0.00196	CcSEcCtD
Rizatriptan—Decreased appetite—Pravastatin—atherosclerosis	0.00134	0.00196	CcSEcCtD
Rizatriptan—Pain—Niacin—atherosclerosis	0.00134	0.00196	CcSEcCtD
Rizatriptan—Fatigue—Pravastatin—atherosclerosis	0.00133	0.00194	CcSEcCtD
Rizatriptan—Pain—Pravastatin—atherosclerosis	0.00132	0.00193	CcSEcCtD
Rizatriptan—Constipation—Pravastatin—atherosclerosis	0.00132	0.00193	CcSEcCtD
Rizatriptan—Hypersensitivity—Ezetimibe—atherosclerosis	0.00132	0.00193	CcSEcCtD
Rizatriptan—Asthenia—Lovastatin—atherosclerosis	0.00131	0.00191	CcSEcCtD
Rizatriptan—Pruritus—Lovastatin—atherosclerosis	0.00129	0.00189	CcSEcCtD
Rizatriptan—Asthenia—Ezetimibe—atherosclerosis	0.00129	0.00188	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Niacin—atherosclerosis	0.00128	0.00187	CcSEcCtD
Rizatriptan—Nausea—Rosuvastatin—atherosclerosis	0.00128	0.00187	CcSEcCtD
Rizatriptan—Feeling abnormal—Pravastatin—atherosclerosis	0.00127	0.00186	CcSEcCtD
Rizatriptan—Pruritus—Ezetimibe—atherosclerosis	0.00127	0.00185	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00126	0.00184	CcSEcCtD
Rizatriptan—Hypersensitivity—Simvastatin—atherosclerosis	0.00126	0.00184	CcSEcCtD
Rizatriptan—Diarrhoea—Lovastatin—atherosclerosis	0.00125	0.00182	CcSEcCtD
Rizatriptan—Urticaria—Niacin—atherosclerosis	0.00125	0.00182	CcSEcCtD
Rizatriptan—Abdominal pain—Niacin—atherosclerosis	0.00124	0.00181	CcSEcCtD
Rizatriptan—Body temperature increased—Niacin—atherosclerosis	0.00124	0.00181	CcSEcCtD
Rizatriptan—HTR1B—artery—atherosclerosis	0.00123	0.169	CbGeAlD
Rizatriptan—Urticaria—Pravastatin—atherosclerosis	0.00123	0.00179	CcSEcCtD
Rizatriptan—Asthenia—Simvastatin—atherosclerosis	0.00123	0.00179	CcSEcCtD
Rizatriptan—Diarrhoea—Ezetimibe—atherosclerosis	0.00123	0.00179	CcSEcCtD
Rizatriptan—Abdominal pain—Pravastatin—atherosclerosis	0.00122	0.00178	CcSEcCtD
Rizatriptan—Body temperature increased—Pravastatin—atherosclerosis	0.00122	0.00178	CcSEcCtD
Rizatriptan—Pruritus—Simvastatin—atherosclerosis	0.00121	0.00176	CcSEcCtD
Rizatriptan—Dizziness—Lovastatin—atherosclerosis	0.00121	0.00176	CcSEcCtD
Rizatriptan—HTR1D—artery—atherosclerosis	0.00119	0.164	CbGeAlD
Rizatriptan—Dizziness—Ezetimibe—atherosclerosis	0.00118	0.00173	CcSEcCtD
Rizatriptan—Diarrhoea—Simvastatin—atherosclerosis	0.00117	0.00171	CcSEcCtD
Rizatriptan—Vomiting—Lovastatin—atherosclerosis	0.00116	0.00169	CcSEcCtD
Rizatriptan—Hypersensitivity—Niacin—atherosclerosis	0.00116	0.00169	CcSEcCtD
Rizatriptan—Rash—Lovastatin—atherosclerosis	0.00115	0.00168	CcSEcCtD
Rizatriptan—Dermatitis—Lovastatin—atherosclerosis	0.00115	0.00168	CcSEcCtD
Rizatriptan—Headache—Lovastatin—atherosclerosis	0.00114	0.00167	CcSEcCtD
Rizatriptan—Vomiting—Ezetimibe—atherosclerosis	0.00114	0.00166	CcSEcCtD
Rizatriptan—Hypersensitivity—Pravastatin—atherosclerosis	0.00114	0.00166	CcSEcCtD
Rizatriptan—Dizziness—Simvastatin—atherosclerosis	0.00113	0.00165	CcSEcCtD
Rizatriptan—Rash—Ezetimibe—atherosclerosis	0.00113	0.00165	CcSEcCtD
Rizatriptan—Dermatitis—Ezetimibe—atherosclerosis	0.00113	0.00165	CcSEcCtD
Rizatriptan—Asthenia—Niacin—atherosclerosis	0.00113	0.00164	CcSEcCtD
Rizatriptan—Headache—Ezetimibe—atherosclerosis	0.00112	0.00164	CcSEcCtD
Rizatriptan—Pruritus—Niacin—atherosclerosis	0.00111	0.00162	CcSEcCtD
Rizatriptan—Asthenia—Pravastatin—atherosclerosis	0.00111	0.00162	CcSEcCtD
Rizatriptan—Pruritus—Pravastatin—atherosclerosis	0.00109	0.00159	CcSEcCtD
Rizatriptan—Vomiting—Simvastatin—atherosclerosis	0.00109	0.00159	CcSEcCtD
Rizatriptan—Nausea—Lovastatin—atherosclerosis	0.00109	0.00158	CcSEcCtD
Rizatriptan—Rash—Simvastatin—atherosclerosis	0.00108	0.00157	CcSEcCtD
Rizatriptan—Dermatitis—Simvastatin—atherosclerosis	0.00108	0.00157	CcSEcCtD
Rizatriptan—Diarrhoea—Niacin—atherosclerosis	0.00107	0.00157	CcSEcCtD
Rizatriptan—Headache—Simvastatin—atherosclerosis	0.00107	0.00156	CcSEcCtD
Rizatriptan—Nausea—Ezetimibe—atherosclerosis	0.00106	0.00155	CcSEcCtD
Rizatriptan—Diarrhoea—Pravastatin—atherosclerosis	0.00106	0.00154	CcSEcCtD
Rizatriptan—Dizziness—Niacin—atherosclerosis	0.00104	0.00151	CcSEcCtD
Rizatriptan—Dizziness—Pravastatin—atherosclerosis	0.00102	0.00149	CcSEcCtD
Rizatriptan—Nausea—Simvastatin—atherosclerosis	0.00102	0.00148	CcSEcCtD
Rizatriptan—Vomiting—Niacin—atherosclerosis	0.000998	0.00146	CcSEcCtD
Rizatriptan—Rash—Niacin—atherosclerosis	0.000989	0.00144	CcSEcCtD
Rizatriptan—Dermatitis—Niacin—atherosclerosis	0.000988	0.00144	CcSEcCtD
Rizatriptan—Headache—Niacin—atherosclerosis	0.000983	0.00143	CcSEcCtD
Rizatriptan—Vomiting—Pravastatin—atherosclerosis	0.000982	0.00143	CcSEcCtD
Rizatriptan—Rash—Pravastatin—atherosclerosis	0.000974	0.00142	CcSEcCtD
Rizatriptan—Dermatitis—Pravastatin—atherosclerosis	0.000973	0.00142	CcSEcCtD
Rizatriptan—Headache—Pravastatin—atherosclerosis	0.000968	0.00141	CcSEcCtD
Rizatriptan—HTR1B—blood vessel—atherosclerosis	0.000959	0.132	CbGeAlD
Rizatriptan—Nausea—Niacin—atherosclerosis	0.000932	0.00136	CcSEcCtD
Rizatriptan—HTR1D—blood vessel—atherosclerosis	0.000928	0.127	CbGeAlD
Rizatriptan—Nausea—Pravastatin—atherosclerosis	0.000918	0.00134	CcSEcCtD
Rizatriptan—HTR1D—connective tissue—atherosclerosis	0.000476	0.0653	CbGeAlD
Rizatriptan—HTR1B—cardiovascular system—atherosclerosis	0.000428	0.0587	CbGeAlD
Rizatriptan—HTR1D—cardiovascular system—atherosclerosis	0.000414	0.0568	CbGeAlD
Rizatriptan—MAOA—connective tissue—atherosclerosis	0.000362	0.0498	CbGeAlD
Rizatriptan—HTR1A—cardiovascular system—atherosclerosis	0.000345	0.0474	CbGeAlD
Rizatriptan—MAOA—cardiovascular system—atherosclerosis	0.000315	0.0433	CbGeAlD
Rizatriptan—MAOA—adipose tissue—atherosclerosis	0.000278	0.0382	CbGeAlD
Rizatriptan—MAOA—liver—atherosclerosis	0.000195	0.0268	CbGeAlD
Rizatriptan—CYP1A2—liver—atherosclerosis	0.000163	0.0223	CbGeAlD
Rizatriptan—HTR1F—Signaling Pathways—APOA1—atherosclerosis	0.0001	0.000333	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL5—atherosclerosis	9.97e-05	0.000332	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—PIK3CG—atherosclerosis	9.89e-05	0.000329	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—PIK3CG—atherosclerosis	9.68e-05	0.000322	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—ESR1—atherosclerosis	9.66e-05	0.000321	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	9.59e-05	0.000319	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—F2—atherosclerosis	9.54e-05	0.000318	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PRKCG—atherosclerosis	9.48e-05	0.000315	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—KNG1—atherosclerosis	9.44e-05	0.000314	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VWF—atherosclerosis	9.44e-05	0.000314	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AGTR1—atherosclerosis	9.39e-05	0.000312	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOC3—atherosclerosis	9.38e-05	0.000312	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LDLR—atherosclerosis	9.32e-05	0.00031	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—KNG1—atherosclerosis	9.25e-05	0.000308	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CCL2—atherosclerosis	9.21e-05	0.000306	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AGTR1—atherosclerosis	9.19e-05	0.000306	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AGT—atherosclerosis	9.18e-05	0.000306	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PLG—atherosclerosis	9.15e-05	0.000304	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—PIK3CG—atherosclerosis	9.13e-05	0.000304	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL3—atherosclerosis	9.11e-05	0.000303	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CCL2—atherosclerosis	9.02e-05	0.0003	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PLG—atherosclerosis	8.96e-05	0.000298	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—HMOX1—atherosclerosis	8.86e-05	0.000295	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—MAPK3—atherosclerosis	8.75e-05	0.000291	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NCF1—atherosclerosis	8.72e-05	0.00029	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SOCS3—atherosclerosis	8.66e-05	0.000288	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—INS—atherosclerosis	8.65e-05	0.000288	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	8.55e-05	0.000285	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CCL2—atherosclerosis	8.51e-05	0.000283	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—F2—atherosclerosis	8.49e-05	0.000282	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOB—atherosclerosis	8.49e-05	0.000282	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SOCS3—atherosclerosis	8.48e-05	0.000282	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP3—atherosclerosis	8.37e-05	0.000278	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IGF1—atherosclerosis	8.36e-05	0.000278	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AGT—atherosclerosis	8.34e-05	0.000278	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF2—atherosclerosis	8.33e-05	0.000277	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GSTM1—atherosclerosis	8.25e-05	0.000275	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCR2—atherosclerosis	8.23e-05	0.000274	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EDNRA—atherosclerosis	8.23e-05	0.000274	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CYBA—atherosclerosis	8.2e-05	0.000273	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP3—atherosclerosis	8.19e-05	0.000273	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF2—atherosclerosis	8.16e-05	0.000271	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCG1—atherosclerosis	8.13e-05	0.000271	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—PIK3CG—atherosclerosis	8.12e-05	0.00027	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—LPL—atherosclerosis	8.1e-05	0.00027	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOB—atherosclerosis	8.09e-05	0.000269	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PLAT—atherosclerosis	8.02e-05	0.000267	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PARP1—atherosclerosis	8.02e-05	0.000267	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—GHRL—atherosclerosis	8.02e-05	0.000267	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—CXCL8—atherosclerosis	8.02e-05	0.000267	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—EDN1—atherosclerosis	7.96e-05	0.000265	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—SERPINE1—atherosclerosis	7.94e-05	0.000264	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOB—atherosclerosis	7.92e-05	0.000263	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—GPX1—atherosclerosis	7.9e-05	0.000263	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL5—atherosclerosis	7.9e-05	0.000263	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—CXCL8—atherosclerosis	7.85e-05	0.000261	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—EDN1—atherosclerosis	7.79e-05	0.000259	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL5—atherosclerosis	7.73e-05	0.000257	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LPL—atherosclerosis	7.72e-05	0.000257	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—F2—atherosclerosis	7.71e-05	0.000256	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CD36—atherosclerosis	7.7e-05	0.000256	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—FABP4—atherosclerosis	7.65e-05	0.000254	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LCAT—atherosclerosis	7.65e-05	0.000254	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NOS3—atherosclerosis	7.58e-05	0.000252	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LPL—atherosclerosis	7.56e-05	0.000252	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PRKCG—atherosclerosis	7.51e-05	0.00025	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOA4—atherosclerosis	7.51e-05	0.00025	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—PIK3CG—atherosclerosis	7.38e-05	0.000245	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP7A1—atherosclerosis	7.37e-05	0.000245	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PRKCG—atherosclerosis	7.35e-05	0.000245	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SPP1—atherosclerosis	7.31e-05	0.000243	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—MTHFR—atherosclerosis	7.3e-05	0.000243	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—CXCL8—atherosclerosis	7.28e-05	0.000242	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SPP1—atherosclerosis	7.16e-05	0.000238	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARA—atherosclerosis	7.16e-05	0.000238	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—CXCL8—atherosclerosis	7.13e-05	0.000237	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—KNG1—atherosclerosis	7.04e-05	0.000234	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.03e-05	0.000234	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGTR1—atherosclerosis	7e-05	0.000233	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AGT—atherosclerosis	6.93e-05	0.000231	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CCL2—atherosclerosis	6.87e-05	0.000229	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PLG—atherosclerosis	6.82e-05	0.000227	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CYP27A1—atherosclerosis	6.82e-05	0.000227	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOE—atherosclerosis	6.79e-05	0.000226	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PDGFB—atherosclerosis	6.77e-05	0.000225	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—CAV1—atherosclerosis	6.73e-05	0.000224	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—CXCL8—atherosclerosis	6.73e-05	0.000224	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—APOA1—atherosclerosis	6.71e-05	0.000223	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.71e-05	0.000223	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PDGFB—atherosclerosis	6.63e-05	0.00022	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AGT—atherosclerosis	6.61e-05	0.00022	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.55e-05	0.000218	CbGpPWpGaD
Rizatriptan—HTR1F—GPCR downstream signaling—AKT1—atherosclerosis	6.5e-05	0.000216	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—LEP—atherosclerosis	6.47e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOE—atherosclerosis	6.47e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AGT—atherosclerosis	6.47e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SOCS3—atherosclerosis	6.46e-05	0.000215	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALOX15—atherosclerosis	6.46e-05	0.000215	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	6.46e-05	0.000215	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOA2—atherosclerosis	6.46e-05	0.000215	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	6.46e-05	0.000215	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CAV1—atherosclerosis	6.41e-05	0.000213	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—APOA1—atherosclerosis	6.4e-05	0.000213	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—IL6—atherosclerosis	6.4e-05	0.000213	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCG5—atherosclerosis	6.38e-05	0.000212	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.38e-05	0.000212	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOE—atherosclerosis	6.34e-05	0.000211	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—LEP—atherosclerosis	6.34e-05	0.000211	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CAV1—atherosclerosis	6.28e-05	0.000209	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—APOA1—atherosclerosis	6.26e-05	0.000208	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP3—atherosclerosis	6.24e-05	0.000208	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF2—atherosclerosis	6.21e-05	0.000207	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—ESR1—atherosclerosis	6.18e-05	0.000206	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LPA—atherosclerosis	6.16e-05	0.000205	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PIK3CG—atherosclerosis	6.13e-05	0.000204	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—F2—atherosclerosis	6.1e-05	0.000203	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MMP9—atherosclerosis	6.08e-05	0.000202	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—ESR1—atherosclerosis	6.05e-05	0.000201	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOB—atherosclerosis	6.03e-05	0.000201	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—NFKB1—atherosclerosis	6.02e-05	0.0002	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—CXCL8—atherosclerosis	5.98e-05	0.000199	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—F2—atherosclerosis	5.98e-05	0.000199	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—BGN—atherosclerosis	5.97e-05	0.000199	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—EDN1—atherosclerosis	5.94e-05	0.000198	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.93e-05	0.000197	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK8—atherosclerosis	5.92e-05	0.000197	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PPARG—atherosclerosis	5.92e-05	0.000197	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOA5—atherosclerosis	5.91e-05	0.000197	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling by GPCR—AKT1—atherosclerosis	5.9e-05	0.000196	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL5—atherosclerosis	5.89e-05	0.000196	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—PIK3CG—atherosclerosis	5.84e-05	0.000194	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—INS—atherosclerosis	5.8e-05	0.000193	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LPL—atherosclerosis	5.76e-05	0.000192	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.74e-05	0.000191	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—PIK3CG—atherosclerosis	5.72e-05	0.00019	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	5.69e-05	0.000189	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.62e-05	0.000187	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PRKCG—atherosclerosis	5.6e-05	0.000186	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—MAPK3—atherosclerosis	5.59e-05	0.000186	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.57e-05	0.000185	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.56e-05	0.000185	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—INS—atherosclerosis	5.53e-05	0.000184	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALOX5—atherosclerosis	5.49e-05	0.000183	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—MAPK3—atherosclerosis	5.48e-05	0.000182	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—VEGFA—atherosclerosis	5.46e-05	0.000182	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SPP1—atherosclerosis	5.45e-05	0.000181	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CCL2—atherosclerosis	5.44e-05	0.000181	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—CXCL8—atherosclerosis	5.43e-05	0.000181	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—INS—atherosclerosis	5.41e-05	0.00018	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—STAT3—atherosclerosis	5.41e-05	0.00018	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IGF1—atherosclerosis	5.35e-05	0.000178	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CCL2—atherosclerosis	5.33e-05	0.000177	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—ALB—atherosclerosis	5.32e-05	0.000177	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IGF1—atherosclerosis	5.24e-05	0.000174	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—MAPK3—atherosclerosis	5.17e-05	0.000172	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—NOS3—atherosclerosis	5.09e-05	0.000169	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—SERPINE1—atherosclerosis	5.08e-05	0.000169	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.08e-05	0.000169	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PDGFB—atherosclerosis	5.05e-05	0.000168	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—TGFB1—atherosclerosis	5.01e-05	0.000167	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—SERPINE1—atherosclerosis	4.97e-05	0.000165	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NAMPT—atherosclerosis	4.93e-05	0.000164	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AGT—atherosclerosis	4.93e-05	0.000164	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.9e-05	0.000163	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LIPC—atherosclerosis	4.9e-05	0.000163	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOC3—atherosclerosis	4.87e-05	0.000162	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NOS3—atherosclerosis	4.85e-05	0.000161	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LDLR—atherosclerosis	4.84e-05	0.000161	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—LEP—atherosclerosis	4.83e-05	0.000161	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOE—atherosclerosis	4.83e-05	0.000161	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CAV1—atherosclerosis	4.78e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—APOA1—atherosclerosis	4.77e-05	0.000159	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NOS3—atherosclerosis	4.75e-05	0.000158	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CETP—atherosclerosis	4.72e-05	0.000157	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—PTGS2—atherosclerosis	4.65e-05	0.000155	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—ESR1—atherosclerosis	4.61e-05	0.000153	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—F2—atherosclerosis	4.55e-05	0.000151	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—SCARB1—atherosclerosis	4.52e-05	0.000151	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.41e-05	0.000147	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—PIK3CG—atherosclerosis	4.36e-05	0.000145	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—CXCL8—atherosclerosis	4.3e-05	0.000143	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMGCR—atherosclerosis	4.27e-05	0.000142	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—CXCL8—atherosclerosis	4.21e-05	0.00014	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—MAPK3—atherosclerosis	4.17e-05	0.000139	CbGpPWpGaD
Rizatriptan—HTR1D—GPCR downstream signaling—AKT1—atherosclerosis	4.15e-05	0.000138	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—INS—atherosclerosis	4.12e-05	0.000137	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—IL6—atherosclerosis	4.09e-05	0.000136	CbGpPWpGaD
Rizatriptan—HTR1B—GPCR downstream signaling—AKT1—atherosclerosis	4.07e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CCL2—atherosclerosis	4.06e-05	0.000135	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—IL6—atherosclerosis	4e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IGF1—atherosclerosis	3.99e-05	0.000133	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MMP9—atherosclerosis	3.89e-05	0.000129	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.85e-05	0.000128	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—NFKB1—atherosclerosis	3.85e-05	0.000128	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MMP9—atherosclerosis	3.81e-05	0.000127	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ABCA1—atherosclerosis	3.81e-05	0.000127	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	3.79e-05	0.000126	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK8—atherosclerosis	3.78e-05	0.000126	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—IL6—atherosclerosis	3.78e-05	0.000126	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling by GPCR—AKT1—atherosclerosis	3.77e-05	0.000126	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—NFKB1—atherosclerosis	3.77e-05	0.000125	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK8—atherosclerosis	3.7e-05	0.000123	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling by GPCR—AKT1—atherosclerosis	3.69e-05	0.000123	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NOS3—atherosclerosis	3.62e-05	0.00012	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—VEGFA—atherosclerosis	3.49e-05	0.000116	CbGpPWpGaD
Rizatriptan—HTR1F—Signaling Pathways—AKT1—atherosclerosis	3.49e-05	0.000116	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—STAT3—atherosclerosis	3.46e-05	0.000115	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—VEGFA—atherosclerosis	3.42e-05	0.000114	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—STAT3—atherosclerosis	3.39e-05	0.000113	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—MAPK3—atherosclerosis	3.3e-05	0.00011	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—HMOX1—atherosclerosis	3.27e-05	0.000109	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—MAPK3—atherosclerosis	3.24e-05	0.000108	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	3.21e-05	0.000107	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—TGFB1—atherosclerosis	3.21e-05	0.000107	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—TGFB1—atherosclerosis	3.14e-05	0.000104	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOB—atherosclerosis	3.13e-05	0.000104	CbGpPWpGaD
Rizatriptan—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	3.1e-05	0.000103	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—IL6—atherosclerosis	3.05e-05	0.000102	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GSTM1—atherosclerosis	3.04e-05	0.000101	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—LPL—atherosclerosis	2.99e-05	9.94e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—GPX1—atherosclerosis	2.92e-05	9.7e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MMP9—atherosclerosis	2.9e-05	9.65e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	2.87e-05	9.55e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CD36—atherosclerosis	2.84e-05	9.45e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	2.82e-05	9.39e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	2.81e-05	9.36e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.69e-05	8.95e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARA—atherosclerosis	2.64e-05	8.78e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	2.61e-05	8.67e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—STAT3—atherosclerosis	2.58e-05	8.58e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AGT—atherosclerosis	2.56e-05	8.51e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOE—atherosclerosis	2.5e-05	8.33e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—CAV1—atherosclerosis	2.48e-05	8.26e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—APOA1—atherosclerosis	2.48e-05	8.24e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	2.46e-05	8.2e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—IL6—atherosclerosis	2.42e-05	8.04e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	2.39e-05	7.96e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—IL6—atherosclerosis	2.37e-05	7.87e-05	CbGpPWpGaD
Rizatriptan—MAOA—Metabolism—AKT1—atherosclerosis	2.34e-05	7.78e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PIK3CG—atherosclerosis	2.26e-05	7.52e-05	CbGpPWpGaD
Rizatriptan—HTR1D—Signaling Pathways—AKT1—atherosclerosis	2.23e-05	7.42e-05	CbGpPWpGaD
Rizatriptan—HTR1B—Signaling Pathways—AKT1—atherosclerosis	2.18e-05	7.26e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PPARG—atherosclerosis	2.18e-05	7.26e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—INS—atherosclerosis	2.14e-05	7.12e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—ALB—atherosclerosis	1.96e-05	6.53e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—NOS3—atherosclerosis	1.88e-05	6.24e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—IL6—atherosclerosis	1.8e-05	6e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.72e-05	5.71e-05	CbGpPWpGaD
Rizatriptan—HTR1A—Signaling Pathways—AKT1—atherosclerosis	1.66e-05	5.53e-05	CbGpPWpGaD
Rizatriptan—CYP1A2—Metabolism—AKT1—atherosclerosis	8.63e-06	2.87e-05	CbGpPWpGaD
